Before Matching | After Matching | ||||||
---|---|---|---|---|---|---|---|
Variable | Category | Opium use | Control | p-value | Opium use | Control | p-value |
Hypertension | <0.001* | 0.9 | |||||
No | n = 341 (65.8%) | n = 1505 (52.8%) | n = 341 (65.8%) | n = 677 (65.3%) | |||
Yes | n = 177 (34.2%) | n = 1343 (47.2%) | n = 177 (34.2%) | n = 359 (34.7%) | |||
DM | <0.001* | 1 | |||||
No | n = 354 (68.3%) | n = 1623 (57%) | n = 354 (68.3%) | n = 708 (68.3%) | |||
Yes | n = 164 (31.7%) | n = 1225 (43%) | n = 164 (31.7%) | n = 328 (31.7%) | |||
Hyperlipidemia | <0.001* | 0.73 | |||||
No | n = 292 (56.4%) | n = 1306 (45.9%) | n = 292 (56.4%) | n = 573 (55.3%) | |||
Yes | n = 226 (43.6%) | n = 1542 (54.1%) | n = 226 (43.6%) | n = 463 (44.7%) | |||
FBS | 106 (IQR: 93–136) | 115 (IQR: 98–157) | < 0.001* | 106 (IQR: 93–136) | 111 (IQR: 96–137.5) | 0.08 | |
LDL | 94 (IQR: 74–120.75) | 101 (IQR: 79–122) | 0.003* | 94 (IQR: 74–120.75) | 100 (IQR: 76–119) | 0.38 | |
Gender | < 0.001* | 0.32 | |||||
Female | n = 19 (3.7%) | n = 731 (25.7%) | n = 19 (3.7%) | n = 27 (2.6%) | |||
Male | n = 499 (96.3%) | n = 2117 (74.3%) | n = 499 (96.3%) | n = 1009 (97.4%) | |||
Age | 58 (IQR: 52–65) | 61 (IQR: 53–69) | <0.001* | 58 (IQR: 52–65) | 58 (IQR: 51–65.25) | 0.96 | |
Chronic smoking | <0.001* | 0.66 | |||||
No | n = 91 (17.6%) | n = 1758 (61.7%) | n = 91 (17.6%) | n = 193 (18.6%) | |||
Yes | n = 427 (82.4%) | n = 1090 (38.3%) | n = 427 (82.4%) | n = 843 (81.4%) |